| Application no. and date | 01934176.7 (espacenet) (Federated) (European Patent Register), 20010601 | | Patent/reg. no. and date | DK/EP 1292594, 20040901 | | Publication date | 20030319 | | Priority no. and date | EP 00401581, 20000606, EP 01400297, 20010207, EP 01400565, 20010305 | | EP pub. no. and date |
EP 1292594 20030319 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | 100067 | | Inventor | HENNEQUIN, Laurent François André, Z.I. La Pompelle,
Boîte Postale 1050
F-51689 Reims Cedex 2, FR,
PLE, Patrick, Z.I. La Pompelle,
Boîte Postale 1050
F-51689 Reims Cedex 2, FR | | Representative | | | Opponent | | | IPC Class | A61K 31/505, A61P 35/00, C07D 235/06, C07D 401/12, C07D 403/12, C07D 413/12 | | Title | Quinazolinderivater til behandling af tumorer | | Int. application no. | GB2001002424 | | Int. publication no. | WO2001094341 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
